Jenburkt Pharmaceuticals Limited (NSE:JENBURPH)
India · Delayed Price · Currency is INR 953.75
-20.25 (-2.08%)
At close: Nov 9, 2026
Jenburkt Pharmaceuticals Market Cap
Jenburkt Pharmaceuticals has a market cap or net worth of 4.24 billion as of November 10, 2026. Its market cap has decreased by 19.40% in one year.
Market Cap
4.24B
Enterprise Value
3.44B
Revenue
1.71B
Global Rank
n/a
Country Rank
n/a
PE Ratio
12.80
ChartMarket Cap Chart
Since November 21, 2001, Jenburkt Pharmaceuticals's market cap has increased from 33.01M to 4.24B, an increase of 12,731.45%. That is a compound annual growth rate of 21.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 4.24B | -11.93% |
| Dec 31, 2025 | 4.81B | -10.28% |
| Dec 31, 2024 | 5.36B | 78.59% |
| Dec 29, 2023 | 3.00B | 1.25% |
| Dec 30, 2022 | 2.96B | 21.19% |
| Dec 31, 2021 | 2.45B | 24.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ZIM Laboratories | 7.38B |
| Wanbury | 7.02B |
| Kilitch Drugs (India) | 6.99B |
| Trident Lifeline | 5.06B |
| Albert David | 4.53B |
| Jenburkt Pharmaceuticals | 4.24B |
| Medicamen Biotech | 3.77B |
| Astonea Labs | 3.52B |